BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 15006545)

  • 1. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
    Park EJ; Bae JH; Kim SY; Lim JG; Baek WK; Kwon TK; Suh SI; Park JW; Lee IK; Ashcroft FM; Song DK
    Biochem Pharmacol; 2004 Mar; 67(6):1089-96. PubMed ID: 15006545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence microscopy studies with a fluorescent glibenclamide derivative, a high-affinity blocker of pancreatic beta-cell ATP-sensitive K+ currents.
    Zünkler BJ; Wos-Maganga M; Panten U
    Biochem Pharmacol; 2004 Apr; 67(8):1437-44. PubMed ID: 15041461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.
    Lim JG; Lee HY; Yun JE; Kim SP; Park JW; Suh SI; Jang BC; Cho CH; Bae JH; Kim SS; Han J; Park MJ; Song DK
    Biochem Pharmacol; 2004 Sep; 68(5):901-10. PubMed ID: 15294453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
    Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
    J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of the inhibitory effects of clonidine on vascular adenosine triphosphate-sensitive potassium channels.
    Kawahito S; Kawano T; Kitahata H; Oto J; Takahashi A; Takaishi K; Harada N; Nakagawa T; Kinoshita H; Azma T; Nakaya Y; Oshita S
    Anesth Analg; 2011 Dec; 113(6):1374-80. PubMed ID: 22003223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
    Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the molecular composition of K(ATP) channels more complex than originally thought?
    Pountney DJ; Sun ZQ; Porter LM; Nitabach MN; Nakamura TY; Holmes D; Rosner E; Kaneko M; Manaris T; Holmes TC; Coetzee WA
    J Mol Cell Cardiol; 2001 Aug; 33(8):1541-6. PubMed ID: 11448141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM; Tucker SJ; Seino S; Ashcroft FM
    Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels.
    Song DK; Ashcroft FM
    Br J Pharmacol; 2001 May; 133(1):193-9. PubMed ID: 11325810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two types of ATP-sensitive K+ channels in rat ventricular myocytes.
    Wu SN; Wu AZ; Sung RJ
    Life Sci; 2007 Jan; 80(4):378-87. PubMed ID: 17097686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat inwardly rectifying potassium channel Kir6.2: cloning electrophysiological characterization, and decreased expression in pancreatic islets of male Zucker diabetic fatty rats.
    Tokuyama Y; Fan Z; Furuta H; Makielski JC; Polonsky KS; Bell GI; Yano H
    Biochem Biophys Res Commun; 1996 Mar; 220(3):532-8. PubMed ID: 8607800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory modulation of ATP-sensitive potassium channels by gallate-ester moiety of (-)-epigallocatechin-3-gallate.
    Baek WK; Jang BC; Lim JH; Kwon TK; Lee HY; Cho CH; Kim DK; Shin DH; Park JG; Lim JG; Bae JH; Bae JH; Yoo SK; Park WK; Song DK
    Biochem Pharmacol; 2005 Nov; 70(11):1560-7. PubMed ID: 16216226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I; de Lonlay P; Polak M
    Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional modulation of the ATP-sensitive potassium channel by extracellular signal-regulated kinase-mediated phosphorylation.
    Lin YF; Chai Y
    Neuroscience; 2008 Mar; 152(2):371-80. PubMed ID: 18280666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KATP-channels in beta-cells in tissue slices are directly modulated by millimolar ATP.
    Speier S; Yang SB; Sroka K; Rose T; Rupnik M
    Mol Cell Endocrinol; 2005 Jan; 230(1-2):51-8. PubMed ID: 15664451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
    Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
    J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide modulation of pinacidil stimulation of the cloned K(ATP) channel Kir6.2/SUR2A.
    Gribble FM; Reimann F; Ashfield R; Ashcroft FM
    Mol Pharmacol; 2000 Jun; 57(6):1256-61. PubMed ID: 10825398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actions of a novel potent islet beta-cell specific ATP-sensitive K+ channel opener can be modulated by syntaxin-1A acting on sulfonylurea receptor 1.
    Ng B; Kang Y; Elias CL; He Y; Xie H; Hansen JB; Wahl P; Gaisano HY
    Diabetes; 2007 Aug; 56(8):2124-34. PubMed ID: 17496234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
    Proks P; Girard C; Baevre H; Njølstad PR; Ashcroft FM
    Diabetes; 2006 Jun; 55(6):1731-7. PubMed ID: 16731836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic nucleotides enhance the tolbutamide sensitivity of the ATP-dependent K+ channel in mouse pancreatic B cells by their combined actions at inhibitory and stimulatory receptors.
    Schwanstecher C; Dickel C; Panten U
    Mol Pharmacol; 1992 Mar; 41(3):480-6. PubMed ID: 1545776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.